What is Teva Korlym?
Teva Korlym is a brand name for mifepristone (an anti–progesterone medicine) marketed by Teva in some countries. It’s used for a specific endocrine condition where excess cortisol is driven by hormonal mechanisms, depending on local indications and regulatory approvals. [1][2]
What condition does Korlym (mifepristone) treat?
Korlym is used for endogenous Cushing’s syndrome (caused by the body’s own overproduction of cortisol) when other treatments are not an option or have not worked, based on the approved label in a given country. [1]
How does mifepristone (Korlym) work?
Mifepristone blocks the effects of progesterone and glucocorticoid signaling at the receptor level. This helps reduce the clinical impact of cortisol excess by antagonizing glucocorticoid receptors. [1]
What are common side effects people ask about?
Side effects can include low potassium (hypokalemia), headache, nausea/vomiting, and fatigue, with the risk of hormone-related effects that require monitoring (the exact list depends on the official prescribing information). [1][2]
What monitoring is typically needed?
People taking mifepristone generally need regular lab monitoring, especially for potassium, and follow-up to assess response and manage hormone-related effects. [1][2]
Can Korlym interact with other drugs?
Yes. Mifepristone can interact with other medicines, particularly those affecting drug-metabolizing enzymes/transporters, so prescribers typically review the person’s full medication list before starting. [1][2]
Is Korlym the same everywhere, and is Teva the manufacturer?
The product name can vary by country, but Teva Korlym refers to mifepristone supplied/marketed under the Korlym name by Teva in specific regions. The exact strength and authorized indication can differ by country and product labeling. [1][2]
Sources
[1] https://www.accessdata.fda.gov/drugsatfda_docs/label/
[2] https://www.ema.europa.eu/en/medicines